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osting by EAbstract The development of UV and ﬂuorescence spectrophotometric methods for the quantita-
tive determination of alprazolam in dosage forms using As(III)SDS system. The two simple and
sensitive, spectrophotometric and spectroﬂuorimetric methods were developed for the determina-
tion of alprazolam (ALP) in tablets. These methods are based on formation of ALPAs(III) com-
plex in the presence of SDS. The UV-spectrum of 30% methanolic solution of ALP (5 · 105 M) at
pH 6.5 (Mclivaine buffer) was run between 200 and 380 nm. The absorption spectrum of ALP
exhibits two peaks with a kmax. at 255 nm and a weak band at 325 nm. When the spectra of the drug
were run at varying pH in the region 200–380 nm, one isosbestic point at 290 nm was observed,
which indicated the presence of two ionic conditions in solution. The complex exhibited an absorp-
tion maximum at 265 nm and emission peak at 520 nm with respect to the excitation wavelength of
325 nm. The spectrophotometric method was found to be linear in 8.0–17.0 lg ml1 range with
detection limit of 13.520 lg ml1, while 0.05–9.5 lg ml1 range was with detection limit of
1.048 · 102 lg ml1 by spectroﬂuorimetric method. The mean percentage recovery of the added
quantity was found to be 99.54 (spectrophotometric method) and 100.22 (spectroﬂuorimetric
method) and the %RSD are lower than 0.478 and 0.296 determined spectrophotomerically and
spectroﬂuorimtrically, respectively. This indicates that the proposed method is accurate. The appar-
ent ionization constant of ALP was found to be 9.29. The spectra, experimental conditions were set
followed by determination stoichiometry, stability constant and thermodynamic parameters of the
As(III), Co(II), Ni(II), and Zn(II) complexes with ALP at pH 6.5. The proposed methods have been
successfully applied to the assay of ALP in tablets and the results were statistically evaluated.
ª 2010 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.19788197/9837284930.
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lsevier1. Introduction
Alprazolam (ALP) {8-chloro-1-methyl-6-phenyl-4H-s-triazol-
o(4,3-a)(1,4)benzodiazepine} (Fig. 1) belongs to the class of
benzodiazepine with anxiolytic, muscle relaxant, anticonvul-
sant properties which is generally used as a hypnotic and as
a tranquilizer (Abernethy et al., 1983; Dawson et al., 1984;
Maitra et al., 2007). It is most frequently prescribed in the ther-
apy of anxiety as being relatively safe with mild side effects. It
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Figure 1 Chemical structure of alprazolam (ALP).
Table 1 Statistical data of calibration graph for the determi-
nation of ALP using proposed methods.
Parameters Spectrophotometric
method
Spectroﬂuorimetric
method
kmax (nm) 255 kem = 520
kex = 325
Bear’s law
limit (lg ml1)
8.0–17.0 0.05–9.5
Slope (m) 0.362 178.17
Intercept (b) 2.694 280.16
SD of residual (Sy/x) 0.970 72.142
SD of intercept (Sa) 1.113 · 102 0.566
SD of slope (Sb) 1.482 8.434
Correlation
coeﬃcient (r)
0.9875 0.9978
Variance (Sy/x)
2 0.106 0.752
Limit of detection
(lg ml1)
13.520 1.048 · 102
Limit of
quantiﬁcation
(lg ml1)
40.970 3.178 · 103
Number of standard samples, n= 7.
370 A. Mohd et al.has no appreciable solubility in water at physiological pH. It is
rapidly and completely absorbed after oral administration,
with peak levels in plasma occurring within 1–2 h after oral
administration (Greenblatt and Wright, 1993). The predomi-
nant metabolites in human plasma are a0-hydroxy alprazolam,
4-hydroxyalprazolam and a0-benzophenone. The pharmaco-
logical activity of a0-hydroxyalprazolam and 4-hydroxyalp-
razolam is about 60% and 20% less than that of ALP,
respectively, and the benzophenone is essentially inactive
(Sethy and Harris, 1982; Andrisano et al., 1999). ALP was
found to be highly photolabile and special care should be ta-
ken to avoid light exposure during its storage and handling.
Drug photostability constitutes an important current subject
of investigation because the photodegradation process can re-
sult in the loss of potency of the drug and also in adverse ef-
fects due to the formation of minor toxic degradation
products (Albini and Fasani, 1998; Moore and Tonnesen,
1996). A large number of analytical and pharmacological tech-
niques for the determination of some benzodiazepines and
their metabolites have been reported (Salem et al., 2002,
2004; Uddin et al., 2008; Walash et al., 1994) especially in bio-
logical ﬂuid and pharmaceutical formulations (Lozano et al.,
2004).
Since there is no report on the use of metal ion as analytical
reagent for the determination of ALP, we have developed a
highly sensitive spectrophotometric and ﬂuorescence quench-
ing methods for its determination in tablets by complex forma-
tion with As(III) in presence of sodium dodecyl sulfate (SDS).
The complexation of Co(II), Ni(II), and Zn(II) with ALP has
also been investigated by spectrophotometry and ﬂuorescence
spectroscopy although the interaction between ALP and these
metal ions can cause ﬂuorescence quenching. The binding
mechanism, binding constant and binding sites can be ob-
tained using ﬂuorescence quenching study of ALP in presence
of these metal ions. The stoichiometry of the drug to metal
ions was determined by continuous variation method and ﬂuo-
rescence quenching. The absorption spectra of the drug were
run in the pH range 2.25–10.50 to ﬁnd isosbestic point which
indicates the presence of different ionic species formed in solu-
tion. The stability constant and thermodynamic parameters of
the process were also evaluated.2. Experimental
2.1. Equipments
The absorption spectra were obtained with Elico-SL-169
double beam UV–visible spectrophotometer. Fluorescence
emission spectra were scanned with Hitachi-F-2500FL-spetro-
photometer. All potentiometric measurements were done with
Elico-Li-120 pH meter.
2.2. Material and methods
Double distilled water was used throughout. Pure ALP (Sigma
Laboratories Ltd., India) and tablets from Morepen Labs Ltd.
(India), sodium hydroxide, arsenic oxide and metal chloride
(Merck Ltd., Mumbai, India) and HCl (Ranbaxy Fine Chem.
Ltd., India) were used as received.
2.3. Preparation of standard solutions
The stock solution (1 · 102 M) of ALP was prepared by
dissolving 0.3088 g of ALP in 30% aqueous methanol, metal
salt solution (1 · 102 M) and sodium dodecyl sulfate
(1 · 104 M) were prepared in water.
2.4. Procedure for commercial tablets
Thirty tablets (1.5 mg of ALP each) were accurately weighed,
ﬁnely powdered and quantity of equivalent to 25 mg was ex-
tracted by shaking with 25 ml of 30% aqueous methanolic
solution followed by three extractions each with 15 ml of
30% aqueous methanol. It was ﬁltered by Whatman ﬁlter pa-
per No. 42 and made up to 100 ml by the same solvent.
2.5. Spectrophotometric measurements
The solution containing 8.0–17.0 lg ml1 of drug was trans-
ferred into a series of 10 ml volumetric ﬂask. One milliliter
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Figure 2 Absorption spectrum of ALP (5 · 105 M) at pH 6.50
at 25 C.
2
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ine buffer of pH 6.5 were added. The mixture was then made
up to the mark. The absorbance of the resulting solution was
measured at speciﬁc wavelength (nm) cited in Table 1 against
reagent blank.
2.6. Spectroﬂuorimetric measurements
Fluorescence emission spectra were measured at 25 C at
optimized excitation wavelength. To an aliquot of the solu-
tion containing 0.05–9.5 lg ml1 of ALP were added 1 ml
(2 · 109 M) of As(III) solution, 1.5 ml SDS and 1 ml Mcliva-
ine buffer (pH 6.5). The ﬂuorescence intensity of solution was
measured at 520 nm with the excitation at 325 nm against a
reagent blank prepared with the reagent concentration but
not with ALP.
2.7. Determination of stoichiometries binding constant and
binding sites
The stoichiometries, binding constant and binding sites were
determined by spectrophotometric and spectroﬂuorimetric
methods.
2.7.1. Spectrophotometric method
Solutions of equimolar concentration (5 · 105 M) of ALP
and metal ions were prepared. In order to calculate the appar-
ent ionization constant of the drug, its pH was adjusted be-
tween 2.25 and 10.50 by adding sodium hydroxide and
hydrochloric acid (1 · 101 and 1 · 102 M, respectively).
The absorption spectra were recorded 30 min after sample
preparation in the range of 200–380 nm. The binding constant
and ratio of metal to ALP was determined by Job’s method in
the presence of 1.5 ml SDS (1 · 104 M) and 1 ml Mclivaine
buffer (pH 6.5).
2.7.2. Spectroﬂuorimetric method
Solution of the ALP (2.4 · 108 M) and those of metal ions
(0.2 · 1081.2 · 108 M) were prepared. To prepare dilute
solutions, an aliquot of stock was transferred into a 10 ml vol-
umetric ﬂask and made up to the mark with distilled water.
Spectra were recorded 30 min after the sample preparation in
the optimum wavelength range of 480–560 nm and at optimum
excitation wavelength of 325 nm.0
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Figure 3 Effect of pH on complex formation of ALP–As(III)–
SDS system: (1) Mclivaine, (2) BR and (3) acetate buffer.3. Results and discussion
3.1. Spectrophotometric measurements
The UV-spectrum of 30% methanolic solution of ALP
(12.0 lg ml1) at pH 6.5 (Mclivaine buffer) was run between
200 and 380 nm. It exhibits two peaks at 255 nm and a weak
band at 325 nm (Fig. 2). Since the ﬁrst peak is very strong it
was selected for further studies.
The Beer’s law was validated from 8.0 to 17.0 lg ml1 for
ALP. The spectrophotometric method is based on complexa-
tion of ALP with As(III)–SDS system under mild acidic condi-
tion. Under the experimental condition described the linear
regression equation: A= 0.362X  2.694 (r= 0.9875), where
A is the absorbance and X is the concentration in lg/ml. The
apparent molar absorptivity was 3.956 · 104 l/mol cm. Thedetection limit and the limit of quantiﬁcation determined with
the acceptable accuracy and precision were 13.520 and
1.048 · 102 lg ml1, respectively.
The low detection and quantiﬁcation limits showed negligi-
ble scatter of the points with respect to the line of regression.
For optimization of the reaction condition of As(III) with
ALP, several factors have been studied carefully. Concerning
the effect of pH and buffer, it was found that maximum absor-
bance was achieved at pH 6.5 inMclivaine buffer (Fig. 3). Other
buffers, such as borate and acetate buffers having the same pH
were studied and compared with Mclivaine buffer. Mclivaine
buffer was found to be superior to phosphate and borate buf-
fers, since it has the highest absorbance value. This is due to
the hydrolysis ofmetal tometal hydroxide in other buffers (Miy-
ano et al., 1985). It was found that concentration of 5 · 105 M
of As(III) and 1 · 104 M of SDS has maximum absorbance.
3.2. Spectroﬂuorimetric method
The ﬂuorescence emission spectra were run between 480 and
560 nm at optimum excitation wavelength of 325 nm. The
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Figure 4 Fluorescence emission spectra: (1) blank, (2) ALP, (3)
ALP–AS(III)–SDS system, (4) ALP–SDS system.
372 A. Mohd et al.spectra of blank, ALP and ALP–As(III)–SDS system are
shown in Fig. 4. It is observed that maximum emission occurs
at 520 nm with no signiﬁcant change in peak position. The ﬂuo-
rescence intensity of ALP was enhanced in the presence of SDS
but quenched when AS(III) was added to it. Considering the
non-interference effect, stability and lower value of blank signal
the excited wavelength of 325 nm was selected for recording
emission spectra (kem = 520 nm) in the subsequent experiment.
A linear correlation was obtained between the ﬂuorescence
intensity and concentration of ALP in the range 0.05–
9.5 lg ml1 and the correlation coefﬁcient was not less than
0.9944. The concentrations of different samples of ALP in
pharmaceutical formulation were calculated from the regres-
sion equation: F= 178.17X+ 280.16 (X is the concentration
of ALP in lg ml1 and F is the ﬂuorescence intensity of
ALP–As(III)–SDS system at 520 nm with the excitation at
325 nm). The maximum ﬂuorescence intensity were obtained
at pH 6.5 with 0.6 · 105 M of As(III) and 1 · 104 M of SDS.
3.3. Optimum conditions for the reaction
3.3.1. Effect of the acidity
The inﬂuences of different kinds of buffer solutions, such as
Mclivaine, BR and HCl–NaAc on the reaction system were
tested. The results showed that Mclivaine buffer of pH 6.5
was better than other buffers. Optimum pH range for theTable 2 Accuracy and precision for the determination of ALP usin
Method Added amount (lg ml1) Found ±
Spectrophotometric 9.0 8.898 ±
12.0 11.96 ±
15.0 15.02 ±
Spectroﬂuoremetric 1.0 0.99 ± 0
3.0 3.02 ± 0
7.0 7.01 ± 0
a Mean ± SD for ﬁve deteterminations.
b Percentage of relative error.
c Percentage relative standard deviation.reaction was 5.0–7.0. Thus, 1.0 ml of Mclivaine’s buffer of
pH 6.5 was taken in each case.
3.3.2. Effect of the SDS concentration
The results showed that when the concentration of SDS was
1 · 104 M, the values of absorbance and ﬂuorescence inten-
sity reached the maximum. Without enough SDS, the reaction
was incomplete but when SDS is in excess, the absorbance and
ﬂuorescence intensity would decrease because of the formation
of SDS dimer by self-aggregation.
3.3.3. Effect of ionic strength
The effect of ionic strength on the intensities of DI was studied.
The experimental results showed that it had little effect on
spectrum, if NaCl concentration was less than 5 · 102 M.
Therefore, the ion-association reaction should be under a
low ionic strength condition. The effect also indicated that
the electrostatic interaction was a very important factor in this
ion-association.
3.4. Analytical performance
3.4.1. Validation of the proposed methods
The validity of the method for linearity, speciﬁcity, accuracy,
repeatability and precision according to recommendations
were tested (http://www.fda.gov/eder/guidance/4252fnl.pdf
(accessed September 1, 2004)). The results are shown in Table
1. The limits of detection (LOD) were determined by establish-
ing the minimum level at which the analyte can be reliably de-
tected. The LOQ and LOD were calculated according to the
following equation:
LOQ ¼ 10r=S ð1Þ
LOD ¼ 3:3r=S ð2Þ
where r is standard deviation of the intercept of regression line
and S is the slope of calibration curve. The proposed methods
were evaluated for the accuracy as percent relative error (%Er)
and the precision as percent relative standard deviation
(%RSD) (Table 2). The results of determination of ALP in
comparison with other method (Nudelman and Gallardo
Cabrera, 2002) are listed in Tables 3 and 4.3.4.2. Accuracy and precision
The reproducibility or precision of the method was evaluated
by statistical analysis of the regression data regarding standard
deviation of the residuals (Sy/x), the intercept (Sa) and the slopeg proposed methods.
SDa %Erb %RSDc % Recovery
4.261 · 102 1.146 0.478 98.86
5.344 · 102 0.317 0.446 99.68
1.166 · 102 0.146 0.077 100.1
.989 · 102 0.140 0.990 99.86
.894 · 102 0.662 0.296 100.6
.748 · 102 0.256 0.106 100.2
Table 3 Result for determination of ALP in pharmaceutical samples.
Method Sample Label claim (mg per tablet) Found ± SD %RSD % Recovery
Spectrophotometric Alpaz 1.0 SR 1.0 0.997 ± 0.013 1.319 99.76
Alpaz 1.5 SR 1.5 1.508 ± 0.017 1.186 100.5
Spectroﬂuorometric Alpaz 1.0 SR 1.0 1.003 ± 0.015 1.518 100.4
Alpaz 1.5 SR 1.5 1.504 ± 0.013 0.892 100.2
Table 4 Comparison of sensitivities of developed methods with reported method for the determination of ALP.
Methods Linearity LOD Recovery %RSD Literature
Spectroﬂuorimetric 0.8–0.9 · 103 M P105 M 101.4–108.3 2.59–5.92 Nudelman and Gallardo Cabrera (2002)
Specrophotmetric 8.0–17.0 lg ml1 1.048 · 102 lg ml1 98.86–100.1 0.077–0.478 This work
Spectroﬂuorimetric 0.05–9.5 lg ml1 3.178 · 103 lg ml1 99.86–100.6 0.106–.296 This work
UV-absorption and ﬂuorimetric methods for the determination of alprazolam in pharmaceutical formulation 373(Sb). The small values of the ﬁgures point out the low scatter-
ing of the calibration graph and high precision.
3.4.2.1. Accuracy. To test the accuracy of the proposed method
a certain amount of ALP was assayed by the proposed meth-
od. The mean percentage recovery of the added quantity was
found to be 99.54 (spectrophotometric method) and 100.22
(spectroﬂuorimetric method). The results indicate that the pro-
posed method gives accurate results.
3.4.2.2. Precision. The precision assay was done by both these
methods. An amount of 9, 12, 15 lg ml1 of ALP for spectro-
photometric and 1, 3, 7 lg ml1 for spectroﬂuorimetric meth-
od were taken, respectively. The results (Table 2) indicate
that the %RSD value for precision are lower than 0.478 and
0.296 determined spectrophotomerically and spectroﬂuorimet-
rically, respectively.3.4.3. Repeatability
To test the reproducibility of the proposed method, ﬁve repli-
cate analysis were done. The mean percentage recovery was
found to be 99.54 (spectrophotometric method) and 100.22
(spectroﬂuorimetric method), respectively.
3.4.4. Speciﬁcity
The speciﬁcity of the method was veriﬁed by checking any
interference encountered by the excipients of tablets. Lactose
which is frequently co-formulated with ALP did not interfere
with the proposed method.
3.4.5. Robustness of the method
The robustness of the method adopted is demonstrated by the
consistency of the absorbance with the deliberate minor
changes in the experiment, such as volume of As(III)
1.0 ± 0.1 ml and volume of SDS 1.5 ± 0.1 ml. These minor
changes did not affect the absorbance of the reaction product.
3.5. Determination of stoichiometry, binding constant and
binding sites
3.5.1. Spectrophotometric method
Ratio of the two reacting components was determined by Job’s
method (Job, 1928; Siddiqi et al., 2009). Different volumes of
equimolar concentration (5 · 105 M) of both the drug and me-tal ions were taken in all possible ratios and absorbance were
measured at 265 nm, pH 6.5 and t= 25 and 35 C. The Job’s
curves at different temperatures showed the formation of 2:1
(drug–metal) complexes (Fig. 5AD). The obtained curves
have a marked maximum at a molar ratio of 1:0.666 and show
the presence of mononuclear complexes. The stability constant
of the complexes was calculated by the following equation:
K ¼ A=AexCXðCM  A=AexCXÞðCL  nA=AexCXÞn ð3Þ
where K is the binding constant of the metal chelate formed in
solution,M is metal, L is ligand, n= X/(1  X) where X is the
mole fraction of the ligand at maximum absorption. A/Aex is
the ratio of the observed absorbance to that indicated by the
tangent for the same wavelength. CX, CM and CL are the lim-
iting concentration, metal ion and the ligand concentrations,
respectively. The stability constant of complex between ALP
and metal ions is fairly high. The logK increases with increase
in temperature as shown in Table 5.
3.5.1.1. Calculation of apparent ionization constant. When the
spectra of the drug were run at varying pH in the region of
200–380 nm one isosbestic point (Fig. 6), at 290 nm was ob-
served which indicated the presence of two ionic species in
solution (Park et al., 2000; Siddiqi et al., 2009). The apparent
ionization constant (pK0a) of the drug was calculated (9.29) by
the following equation:
pK0a ¼ pHþ logfðAI  AMÞ=ðA AMÞg ð4Þ
where AI= absorbance of drug in basic medium,
AM = absorbance of drug in acidic medium, A= absorbance
of drug in aqueous medium.
3.5.2. Spectroﬂuorimetric method
The ﬂuorescence emission spectra of the pure drug scanned in
480–560 nm range (at excitation wavelength of 325 nm) are
markedly different from its UV spectrum (Fig. 7AD) in the
presence of concentrations of metal ions. Although, the ﬂuo-
rescence intensity of ALP–SDS system decreases steadily with
increasing concentration of metal ions, the emission maxima
remain unchanged. As there was no signiﬁcant kem shift with
the addition of metal ions, it indicated that metal ion can
quench intrinsic ﬂuorescence of ALP and that the interaction
between ALP and metal ion indeed existed without inducing
any conformational change in it under the experimental
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Figure 5 Continuous variation curves of complexes of ALP with (A) As(III), (B) Co(II), (C) Ni(II) and (D) Zn(II) at 25 and 35 C.
Table 5 Stability constant and thermodynamic parameters of ALP complexes.
Metal ions log K (DG) (kJ mol1) (DH) (kJ mol1) (DS) (kJ mol1 K1)
25 C 35 C 25 C 35 C 25 C 35 C
As(III) 13.399 14.897 76.452 87.852 2.509 0.264 0.293
Co(II) 13.265 14.731 75.688 86.734 2.456 0.262 0.289
Ni(II) 13.145 14.659 75.003 86.448 2.541 0.260 0.288
Zn(II) 13.098 14.416 74.735 85.015 2.208 0.258 0.283
374 A. Mohd et al.condition. Quenching can occur by a variety of molecular
interactions, viz. excited state reactions, molecular rearrange-
ment, energy transfer, ground state complex formation (static
quenching) and collisional or dynamic quenching. Static and
dynamic quenching can be distinguished from their depen-
dence on temperature and excited state life time. Dynamic
quenching is diffusion controlled because the quencher must
diffuse to the ﬂuorophore during the life time of the excited
state. If the KSV decreased with increased temperature it maybe concluded that the quenching process is static rather than
dynamic (Guo et al., 2004; Wang et al., 2007). Static quenching
refers to the existence of a sphere of effective quenching or the
formation of a ground state non-ﬂuorescent complex, whereas
collisional or dynamic quenching involves the collision and
subsequent formation of a transient complex between an ex-
cited state ﬂuorophore and a ground state quencher. The ex-
cited state complex dissociates upon radiative and non-
radiative deactivation. In order to conﬁrm the quenching
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Figure 6 Absorption spectra of ALP (5 · 105 M) in (2.25–
10.50) pH range (1–7: 2.25, 3.50, 5.0, 6.50, 7.50, 8.50, 10.50).
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Figure 7 Fluorescence quenching spectrum (at kex 325 nm) of ALP w
2.4 · 108 M ALP, from (2) to 7:0.2 · 108, 0.4 · 108, 0.6 · 108, 0.8
UV-absorption and ﬂuorimetric methods for the determination of alprazolam in pharmaceutical formulation 375mechanism the procedure of ﬂuorescence quenching was ﬁrst
assumed to be dynamic. For dynamic quenching, the mecha-
nism can be described by the Stern–Volmer equation (Lako-
wicz, 1999):
F0=F ¼ 1þ KSV½Q ð5Þ
where F0 and F are the ﬂuorescence intensities in the absence
and presence of the quencher, respectively. KSV is the dynamic
quenching constant (Table 6). Fig. 8AD displays the
Stern–Volmer plots of quenching of the ALP by metal ions
at different temperatures. For static quenching, the relation-
ship between intensity and the concentration of quencher can
be described by the binding constant formula (Feng et al.,
1996; Xu et al., 1997);
logðF0  FÞ=F ¼ logKþ n log½Q ð6Þ
where K is the binding constant and n is the number of
binding sites per ALP. Fig. 9AD show double-logarithm
curve and Table 6 shows the corresponding calculated(B)    Co(II)
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ith (A) As(III), (B) Co(II), (C) Ni(II) and (D) Zn(II) at 25 C, (1)
· 108, 1.0 · 108, 1.2 · 108 M of metal ions.
Table 6 Stern–Volmer constant (KSV), binding constant (log K), binding site (n) and regression coefﬁcient (r) at 25 and 35 C.
Metal ions KSV (mol
1) log K n r
25 C 35 C 25 C 35 C 25 C 35 C 25 C 35 C
As(III) 2.98 · 108 2.90 · 108 13.419 14.922 1.874 2.029 0.9944 0.9920
Co(II) 3.21 · 108 2.92 · 108 13.360 14.826 1.848 1.986 0.9860 0.9974
Ni(II) 2.89 · 108 2.82 · 108 13.305 14.787 1.812 1.924 0.9866 0.9906
Zn(II) 3.11 · 108 3.02 · 108 13.102 14.505 1.828 1.957 0.9852 0.9968
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Figure 8 Stern–Volmer plots of ALP with (A) As(III), (B) Co(II), (C) Ni(II) and (D) Zn(II) at 25 and 35 C.
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are larger than 0.9852, suggesting interaction of metal ions
with ALP which agrees well with the site-binding model
underlying Eq. (6).
3.5.3. Thermodynamic parameters and nature of binding forces
Considering the dependence of the binding constant on the
temperature a thermodynamic process was considered to be
responsible for this interaction and analyzed in order to
further characterize the forces acting between ALP and metalions. The thermodynamic parameters enthalpy (DH), entropy
(DS), and free energy (DG) are the main evidences to determine
the binding mode. If the temperature does not vary signiﬁ-
cantly, the enthalpy changes (DH) can be regarded as constant.
The DG, DH and DS can be estimated from the following stan-
dard equations:
DG ¼ 2:303RT logK ¼ DH TDS ð7Þ
logK2=K1 ¼ ½1=T1  1=T2DH=2:303R ð8Þ
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Figure 9 Double reciprocal plots of ALP with (A) As(II), (B) Co(II), (C) Ni(II) and (D) Zn(II) at 25 and 35 C.
Table 7 Thermodynamic parameters at 25 and 35 C.
Metal ions DG (kJ mol1) DH (kJ mol1) DS (kJ mol1 K1)
25 C 35 C 25 C 35 C
As(III) 76.566 88.126 2.518 0.265 0.294
Co(II) 76.230 87.433 2.054 0.262 0.290
Ni(II) 75.916 87.203 2.483 0.263 0.291
Zn(II) 74.775 85.540 2.350 0.258 0.285
UV-absorption and ﬂuorimetric methods for the determination of alprazolam in pharmaceutical formulation 377The thermodynamic parameters for the interaction of metal
ions with ALP are shown in Tables 5 and 7. The negative value
of DG means that the interaction was spontaneous while the
+ve DS value is characteristic of chelation. It occurs because
the water molecules that are normally arranged in an orderly
fashion around the drug and metal ions have acquired a ran-
dom conﬁguration as a result of chelation. It indicates a gain
in conﬁgurational entropy (Calvin and Melchior, 1948). The
+ve value of DH indicated that the processes were endother-
mic and binding between metal ions and ALP is mainly DS-
driven, with little contribution from the enthalpy factor.4. Conclusion
The proposed methods are simple and sensitive. These do not
require any pretreatment of the drug and tedious extraction
procedure. The methods have wider linear range with good
accuracy and precision. The proposed methods are accurate
and precise. It can be extended for routine analysis of ALP
in pharmaceutical formulation, hospital and research labora-
tory. Since the stability increases in the presence of the metal
ions the drug may be absorbed with traces of essential
elements.
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